Sarah Hsu

Sarah Hsu, MBA, is a patient-centric marketing and communications leader with extensive experience in the healthcare industry. They began their career as a reporter at The Wall Street Journal, where they reported on the complexities of the U.S. healthcare system. Currently, as the Industry Engagement Lead for Clinical Trials at TrialX, they engage with industry leaders to inform product strategy and company communications. Previously, Sarah held various significant roles at Pfizer, including Director of Clinical Trial Participant Experience, where they led initiatives to enhance volunteer recruitment for clinical trials, and contributed to the successful launch of a gene therapy candidate for Duchenne muscular dystrophy. Sarah is also pursuing an MBA at Columbia Business School while holding an AB in History from Dartmouth College.